Ryosuke Okamura1, Koya Hida2, Suguru Hasegawa2, Yoshiharu Sakai2, Madoka Hamada3, Masayoshi Yasui4, Takao Hinoi5, Masahiko Watanabe6. 1. Department of Surgery, Kyoto University Hospital, 54 Shogoin-Kawara-Cho, Sakyo-ku, Kyoto, Japan. rokamura@kuhp.kyoto-u.ac.jp. 2. Department of Surgery, Kyoto University Hospital, 54 Shogoin-Kawara-Cho, Sakyo-ku, Kyoto, Japan. 3. Department of Surgery, Kochi Health Sciences Center, Kochi, Japan. 4. Department of Surgery, Osaka National Hospital, Osaka, Japan. 5. Department of Gastroenterological and Transplant Surgery, Hiroshima University Hospital, Hiroshima, Japan. 6. Department of Surgery, Kitasato University, Tokyo, Japan.
Abstract
PURPOSE: This study aimed to assess the effect of intraoperative blood loss (IBL) on short- and long-term outcomes of colorectal cancer surgery for very elderly patients. METHODS: We acquired the data of consecutive patients aged 80 years or older who underwent elective radical surgery for stage I to III colorectal cancer between January 2003 and December 2007 in 41 institutions. The patients were divided into high and low IBL groups, and the differences in postoperative morbidity and survival between the two groups were primarily assessed. Eleven factors were treated as potential confounders in multivariate analyses. RESULTS: A total of 1554 patients were eligible for this study, with an age range of 80-103 years. Median IBL was 71 ml (interquartile range, 25 to 200 ml), and 412 patients had IBL ≥200 ml. Morbidity was 46% among patients with IBL ≥200 ml, compared with 30 % among those with IBL <200 ml (p < 0.001). Patients with IBL ≥200 ml had worse overall survival rates and recurrence-free survival rates at 1, 3, and 5 years than those with IBL <200 ml. In multivariate analyses, IBL ≥200 ml was identified as an independent risk factor for postoperative adverse events (odds ratio (OR) 1.41, 95% confidence interval (CI) 1.08 to 1.86), overall survival (hazard ratio (HR) 1.34, 95% CI 1.04 to 1.72), and recurrence-free survival (HR 1.29, 95% CI 1.03 to 1.62). CONCLUSION: The degree of IBL is significantly associated with postoperative morbidity and survival in very elderly colorectal cancer patients.
PURPOSE: This study aimed to assess the effect of intraoperative blood loss (IBL) on short- and long-term outcomes of colorectal cancer surgery for very elderly patients. METHODS: We acquired the data of consecutive patients aged 80 years or older who underwent elective radical surgery for stage I to III colorectal cancer between January 2003 and December 2007 in 41 institutions. The patients were divided into high and low IBL groups, and the differences in postoperative morbidity and survival between the two groups were primarily assessed. Eleven factors were treated as potential confounders in multivariate analyses. RESULTS: A total of 1554 patients were eligible for this study, with an age range of 80-103 years. Median IBL was 71 ml (interquartile range, 25 to 200 ml), and 412 patients had IBL ≥200 ml. Morbidity was 46% among patients with IBL ≥200 ml, compared with 30 % among those with IBL <200 ml (p < 0.001). Patients with IBL ≥200 ml had worse overall survival rates and recurrence-free survival rates at 1, 3, and 5 years than those with IBL <200 ml. In multivariate analyses, IBL ≥200 ml was identified as an independent risk factor for postoperative adverse events (odds ratio (OR) 1.41, 95% confidence interval (CI) 1.08 to 1.86), overall survival (hazard ratio (HR) 1.34, 95% CI 1.04 to 1.72), and recurrence-free survival (HR 1.29, 95% CI 1.03 to 1.62). CONCLUSION: The degree of IBL is significantly associated with postoperative morbidity and survival in very elderly colorectal cancerpatients.
Entities:
Keywords:
80 years or older; Blood loss; Colorectal cancer; Elderly
Authors: Stefan W Leichtle; Nicolas J Mouawad; Richard Lampman; Bonita Singal; Robert K Cleary Journal: J Am Coll Surg Date: 2011-02 Impact factor: 6.113
Authors: Rajiv Kumar; Kunal Jain; Carol Beeke; Timothy J Price; Amanda R Townsend; Rob Padbury; David Roder; Graeme P Young; Alison Richards; Christos S Karapetis Journal: Cancer Date: 2012-09-18 Impact factor: 6.860
Authors: C Simillis; M Charalambides; A Mavrou; T Afxentiou; M P Powar; J Wheeler; R J Davies; N S Fearnhead Journal: Tech Coloproctol Date: 2022-09-22 Impact factor: 3.699
Authors: M Charalambides; T Afxentiou; G Pellino; M P Powar; N S Fearnhead; R J Davies; J Wheeler; C Simillis Journal: Tech Coloproctol Date: 2022-02-07 Impact factor: 3.699
Authors: Maria Charalambides; Athina Mavrou; Thomas Jennings; Michael P Powar; James Wheeler; R Justin Davies; Nicola S Fearnhead; Constantinos Simillis Journal: Int J Colorectal Dis Date: 2021-10-26 Impact factor: 2.571
Authors: Piotr Małczak; Magdalena Mizera; Grzegorz Torbicz; Jan Witowski; Piotr Major; Magdalena Pisarska; Michał Wysocki; Marcin Strzałka; Andrzej Budzyński; Michał Pędziwiatr Journal: Wideochir Inne Tech Maloinwazyjne Date: 2018-05-16 Impact factor: 1.195
Authors: Hugo Teixeira Farinha; David Martin; Audrey Ramó; Martin Hübner; Nicolas Demartines; Dieter Hahnloser Journal: Int J Colorectal Dis Date: 2021-04-16 Impact factor: 2.571